Novel neuroprotective action of prothymosin alpha-derived peptide against retinal and brain ischemic damages

Journal of Neurochemistry

Volumn 125, Issue 5, 2013, Pages 713-723

  Halder, Sebok Kumar ^a   Matsunaga, Hayato ^a   Yamaguchi, Haruka ^a   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

blood vessel; brain ischemia; neuroprotective peptide; prothymosin alpha; retinal ischemia

Indexed keywords

AMINO ACID; PEPTIDE DERIVATIVE; PEPTIDE P30; PROTHYMOSIN ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN ISCHEMIA; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PHOTORECEPTOR CELL; PRIORITY JOURNAL; RETINA BIPOLAR GANGLION CELL; RETINA INJURY; RETINA ISCHEMIA;

AMINO ACID SEQUENCE; ANIMALS; BRAIN ISCHEMIA; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEUROPROTECTIVE AGENTS; PROTEIN PRECURSORS; RATS; RETINAL DISEASES; THYMOSIN;

EID: 84878019580     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12132     Document Type: Article

References (55)

1. Archakov A. I., Govorun V. M., Dubanov A. V., Ivanov Y. D., Veselovsky A. V., Lewi P., and, Janssen P., (2003) Protein-protein interactions as a target for drugs in proteomics. Proteomics 3, 380-391.
2. Asi H., and, Perlman I., (1992) Relationships between the electroretinogram a-wave, b-wave and oscillatory potentials and their application to clinical diagnosis. Doc. Ophthalmol. 79, 125-139.
3. Beck H., and, Plate K. H., (2009) Angiogenesis after cerebral ischemia. Acta Neuropathol. 117, 481-496.
4. Bejot Y., Prigent-Tessier A., Cachia C., Giroud M., Mossiat C., Bertrand N., Garnier P., and, Marie C., (2011) Time-dependent contribution of non neuronal cells to BDNF production after ischemic stroke in rats. Neurochem. Int. 58, 102-111.
5. Blanco R. E., Soto I., Duprey-Diaz M., and, Blagburn J. M., (2008) Upregulation of brain-derived neurotrophic factor by application of fibroblast growth factor-2 to the cut optic nerve is important for long term survival of retinal ganglion cells. J. Neurosci. Res. 86, 3382-3392.
6. Buckingham B. P., Inman D. M., Lambert W., Oglesby E., Calkins D. J., Steele M. R., Vetter M. L., Marsh-Armstrong N., and, Horner P. J., (2008) Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J. Neurosci. 28, 2735-2744.
7. Danielli R., Fonsatti E., Calabrò L., Giacomo A. M., and, Maio M., (2012) Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond. Ann. N. Y. Acad. Sci. 1270, 8-12.
8. Dong G., Callegari E. A., Gloeckner C. J., Ueffing M., and, Wang H., (2012) Prothymosin-α interacts with mutant huntingtin and suppresses its cytotoxicity in cell culture. J. Biol. Chem. 287, 1279-1289.
9. Dvoriantchikova G., Barakat D. J., Hernandez E., Shestopalov V. I., and, Ivanov D., (2010) Liposome-delivered ATP effectively protects the retina against ischemia-reperfusion injury. Mol. Vis. 16, 2882-2890.
10. Feigin V. L., (2005) Stroke epidemiology in the developing world. Lancet 365, 2160-2161.
11. Flynn R. W., MacWalter R. S., and, Doney A. S., (2008) The cost of cerebral ischaemia. Neuropharmacology 55, 250-256.
12. Fornage M., (2009) Genetics of stroke. Curr. Atheroscler. Rep. 11, 167-174.
13. Fujita R., and, Ueda H., (2003) Protein kinase C-mediated cell death mode switch induced by high glucose. Cell Death Differ. 10, 1336-1347.
14. Fujita R., and, Ueda H., (2007) Prothymosin-alpha1 prevents necrosis and apoptosis following stroke. Cell Death Differ. 14, 1839-1842.
15. Fujita R., Ueda M., Fujiwara K., and, Ueda H., (2009) Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition. Cell Death Differ. 16, 349-358.
16. Garaci E., Favalli C., Pica F., et al,. (2007) Thymosin alpha 1: from bench to bedside. Ann. N. Y. Acad. Sci. 1112, 225-234.
17. Goldstein A. L., and, Goldstein A. L., (2009) From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opin. Biol. Ther. 9, 593-608.
18. Gozes I., (2007) Activity-dependent neuroprotective protein: from gene to drug candidate. Pharmacol. Ther. 114, 146-154.
19. Halder S. K., Matsunaga H., and, Ueda H., (2012) Neuron-specific non-classical release of prothymosin alpha, a novel neuroprotective DAMPs. J. Neurochem. 123, 262-275.
20. Hofmeijer J., and, van Putten M. J., (2012) Ischemic cerebral damage: an appraisal of synaptic failure. Stroke 43, 607-615.
21. Iadecola C., and, Anrather J., (2011) The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796-808.
22. Jiang X., Kim H. E., Shu H., et al,. (2003) Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299, 223-226.
23. Karapetian R. N., Evstafieva A. G., Abaeva I. S., et al,. (2005) Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol. Cell. Biol. 25, 1089-1099.
24. Korada S., Zheng W., Basilico C., Schwartz M. L., and, Vaccarino F. M., (2002) Fibroblast growth factor 2 is necessary for the growth of glutamate projection neurons in the anterior neocortex. J. Neurosci. 22, 863-875.
25. Krysl D., Deykun K., Lambert L., Pokorny J., and, Mares J., (2012) Perifocal and remote blood-brain barrier disruption in cortical photothrombotic ischemic lesion and its modulation by the choice of anesthesia. J. Physiol. Pharmacol. 63, 127-132.
26. Madinier A., Bertrand N., Mossiat C., Prigent-Tessier A., Beley A., Marie C., and, Garnier P., (2009) Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS ONE 4, e8101.
27. Maiese K., Li F., and, Chong Z. Z., (2004) Erythropoietin in the brain: can the promise to protect be fulfilled?. Trends Pharmacol. Sci. 25, 577-583.
28. Matsunaga H., and, Ueda H., (2010) Stress-induced non-vesicular release of prothymosin-alpha initiated by an interaction with S100A13, and its blockade by caspase-3 cleavage. Cell Death Differ. 17, 1760-1772.
29. Meade A. J., Meloni B. P., Mastaglia F. L., and, Knuckey N. W., (2009) The application of cell penetrating peptides for the delivery of neuroprotective peptides/proteins in experimental cerebral ischaemia studies. J. Exp. Stroke Transl. Med. 2, 22-40.
30. Mosoian A., Teixeira A., Burns C. S., Sander L. E., Gusella L. G., He C., Blander J. M., Klotman P., and, Klotman M. E., (2010) Prothymosin-α inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction. Proc. Natl Acad. Sci. USA 107, 10178-10183.
31. Nagai N., Van Hoef B., and, Lijnen H. R., (2007) Plasminogen activator inhibitor-1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice. J. Thromb. Haemost. 5, 1726-1731.
32. Neroev V. V., Zueva M. V., and, Kalamkarov G. R., (2010) Molecular mechanisms of retinal ischemia. Vestn. oftalmol. 126, 59-64.
33. Osborne N. N., Casson R. J., Wood J. P., Chidlow G., Graham M., and, Melena J., (2004) Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23, 91-147.
34. Paolucci S., Antonucci G., Grasso M. G., Bragoni M., Coiro P., Angelis D. D., Morelli D., Venturiero V., Troisi E., and, Pratesi L., (2003) Functional outcome of ischemic and hemorrhagic stroke patients after inpatient rehabilitation: A matched comparison. Stroke 34, 2861-2865.
35. Patel L. N., Zaro J. L., and, Shen W. C., (2007) Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm. Res. 24, 1977-1992.
36. Paul R., Zhang Z. G., Eliceiri B. P., Jiang Q., Boccia A. D., Zhang R. L., Chopp M., and, Cheresh D. A., (2001) Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat. Med. 7, 222-227.
37. Pierluigi B., D'Angelo C., Fallarino F., Moretti S., Zelante T., Bozza S., De Luca A., Bistoni F., Garaci E., and, Romani L., (2010) Thymosin alpha1: the regulator of regulators?. Ann. N. Y. Acad. Sci. 1194, 1-5.
38. Prasad S. S., Kojic L., Wen Y. H., Chen Z., Xiong W., Jia W., and, Cynader M. S., (2010) Retinal gene expression after central retinal artery ligation: effects of ischemia and reperfusion. Invest. Ophthalmol. Vis. Sci. 51, 6207-6219.
39. Rhee K. D., Ruiz A., Duncan J. L., Hauswirth W. W., Lavail M. M., Bok D., and, Yang X. J., (2007) Molecular and cellular alterations induced by sustained expression of ciliary neurotrophic factor in a mouse model of retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 48, 1389-1400.
40. Sherry D. M., Mitchell R., Standifer K. M., and, du Plessis B., (2006) Distribution of plasma membrane-associated syntaxins 1 through 4 indicates distinct trafficking functions in the synaptic layers of the mouse retina. BMC Neurosci. 7, 54.
41. Sims N. R., and, Muyderman H., (2010) Mitochondria, oxidative metabolism and cell death in stroke. Biochim. Biophys. Acta 1802, 80-91.
42. Siren A. L., Fratelli M., Brines M., et al,. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl Acad. Sci. USA 98, 4044-4049.
43. Skopeliti M., Kratzer U., Altenberend F., Panayotou G., Kalbacher H., Stevanovic S., Voelter W., and, Tsitsilonis O. E., (2007) Proteomic exploitation on prothymosin alpha-induced mononuclear cell activation. Proteomics 7, 1814-1824.
44. Skopeliti M., Iconomidou V. A., Derhovanessian E., Pawelec G., Voelter W., Kalbacher H., Hamodrakas S. J., and, Tsitsilonis O. E., (2009) Prothymosin alpha immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a beta-sheet conformation in a sequence-specific manner. Mol. Immunol. 46, 784-792.
45. Tanaka Y., Koizumi C., Marumo T., Omura T., and, Yoshida S., (2007) Serum S100B is a useful surrogate marker for long-term outcomes in photochemically-induced thrombotic stroke rat models. Life Sci. 81, 657-663.
46. Ueda H., (2008) Prothymosin alpha plays a key role in cell death mode-switch, a new concept for neuroprotective mechanisms in stroke. Naunyn Schmiedebergs Arch. Pharmacol. 377, 315-323.
47. Ueda H., (2009) Prothymosin alpha and cell death mode switch, a novel target for the prevention of cerebral ischemia-induced damage. Pharmacol. Ther. 123, 323-333.
48. Ueda H., and, Fujita R., (2004) Cell death mode switch from necrosis to apoptosis in brain. Biol. Pharm. Bull. 27, 950-955.
49. Ueda H., Fujita R., Yoshida A., Matsunaga H., and, Ueda M., (2007) Identification of prothymosin-alpha1, the necrosis-apoptosis switch molecule in cortical neuronal cultures. J. Cell Biol. 176, 853-862.
50. Ueda H., Matsunaga H., Uchida H., and, Ueda M., (2010) Prothymosin alpha as robustness molecule against ischemic stress to brain and retina. Ann. N. Y. Acad. Sci. 1194, 20-26.
51. Ueda H., Matsunaga H., and, Halder S. K., (2012) Prothymosin α plays multifunctional cell robustness roles in genomic, epigenetic, and nongenomic mechanisms. Ann. N. Y. Acad. Sci. 1269, 34-43.
52. Watt P. M., (2006) Screening for peptide drugs from the natural repertoire of biodiverse protein folds. Nat. Biotechnol. 24, 177-183.
53. White B. C., Sullivan J. M., DeGracia D. J., O'Neil B. J., Neumar R. W., Grossman L. I., Rafols J. A., and, Krause G. S., (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 179, 1-33.
54. Witmer M. T., Pavan P. R., Fouraker B. D., and, Levy-Clarke G. A., (2011) Acute retinal necrosis associated optic neuropathy. Acta Ophthalmol. 89, 599-607.
55. Yin K. J., Deng Z., Huang H., Hamblin M., Xie C., Zhang J., and, Chen Y. E., (2010) miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol. Dis. 38, 17-26.